(Q39152521)
Statements
1 reference
ASCEND-8: A Randomized Phase 1 Study of Ceritinib, 450 mg or 600 mg, Taken with a Low-Fat Meal versus 750 mg in Fasted State in Patients with Anaplastic Lymphoma Kinase (ALK)-Rearranged Metastatic Non-Small Cell Lung Cancer (NSCLC). (English)
1 reference
Dong-Wan Kim
Scott A Laurie
Mark McKeage
Keunchil Park
Sang-We Kim
Marwan Ghosn
Andrea Ardizzoni
Richard Yu
Karen Osborne
Wen Gu
Jeffrey W Scott
Vanessa Q Passos
Yvonne Y Lau
17 July 2017
1 reference